silence therapeutics plc
(SLN:London Stock Exchange)
Former Member of Scientific Advisory Board, Silence Therapeutics plc
|Age||Total Calculated Compensation||This person is connected to 12 board members in 1 different organizations across 2 different industries.|
See Board Relationships
Dr. Bertram Wiedenmann serves as Professor of Internal Medicine, Gastroenterology and Endocrinology at the Humboldt University of Berlin. Dr. Wiedenmann serves as Chair of Hepatology and Gastroenterology & Interdisciplinary Centre of Metabolism at the Humboldt University of Berlin, Germany. Dr. Wiedenmann is a Member of Clinical Advisory Board at Shire Orphan Therapies GmbH. Dr. Wiedenmann is a member of the Medical Faculty Charité, Humboldt University, Berlin, Germany. ...
1 Lyric SquarePhone: 44 20 3700 9711
London, Greater London W6 0NB
Board Members Memberships*There is no Board Members Memberships data available.
Education*There is no Education data available.
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|J. Michael French||Chairman, Chief Executive Officer and President|
Marina Biotech, Inc.
|Peter French B.Sc, M.Sc, Ph.D., MBA||Chief Executive Officer, Managing Director and Director|
Benitec Biopharma Limited
|Mark W. Schwartz Ph.D.||Chief Executive Officer, President, Director and Member of Ad Hoc (Strategy, Pricing, Etc) Committee|
Galena Biopharma, Inc.
|Mark Joseph Murray Ph.D.||Chief Executive Officer, President and Director|
Tekmira Pharmaceuticals Corporation
|Kleanthis G. Xanthopoulos Ph.D.||Chief Executive Officer, President, Principal Financial & Accounting Officer and Director|
Regulus Therapeutics Inc.
|$600.0K||Compensation as of Fiscal Year 2014.|